Population-based age- and sex-specific percentiles for 30-year cardiovascular disease (CVD) risk have been developed.

Patients with symptomatic intracranial atherosclerosis who show impaired distal perfusion face a significantly higher risk for early stroke recurrence.

The CDC has updated a webpage about vaccines and autism, changing language that for years clearly stated there is no link between them.

Tonmya (cyclobenzaprine HCl sublingual tablets) is now available for the treatment of adults with fibromyalgia, according to Tonix Pharmaceuticals.

Researchers have found that there is a link between migraine and hypertension among adolescent patients, especially patients with severe migraine.

Tenecteplase shows no benefit over standard care for 90-day functional recovery in patients with minor ischemic stroke and disabling deficits.

Among patients with OSA and comorbid chronic conditions, there is a dose-dependent relationship between PAP usage and healthcare resource utilization.

The FDA has approved new safety warnings and a revised indication for Elevidys following multiple reports of fatal acute liver failure in non-ambulatory patients with DMD.

Higher education is linked to better episodic memory in adults aged 90 years and older, though effects on hippocampal volume differ across racial groups.

Sleep-related disorders are significantly associated with hypertension in postmenopausal US women, according to a recent study.

Tyruko (natalizumab-sztn), a biosimilar to Tysabri (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.

Most countries involved in clinical trials for FDA approvals do not gain timely physical access to the medicines that they help evaluate.